Assistant Professor, Internal Medicine, Wayne State University School of Medicine
Hematology
Dr. Abhinav Deol, MD
|
|
Give Review
Abhinav Deol practices Hematology. He graduated from Wayne State University School of Medicine. Wayne State University School of Medicine is ranked 63/85 in Research/PrimaryCare. Doctor Abhinav Deol, MD is a published physician. He published 16 publications, including: 'Targeting Clonogenic Myeloma Precursor Cells Decreases These Cells and Induces Transferable Antimyeloma Immunity.' Doctor Abhinav Deol, MD is registered with Medicare and accepts Medicare payments.
Publications
- Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies.
- Targeting Clonogenic Myeloma Precursor Cells Decreases These Cells and Induces Transferable Antimyeloma Immunity.
- Low blood lymphocyte count at 30 days post transplant predicts worse Acute GVHD and survival but not relapse in a large retrospective cohort.
- Incidence, Risk Factors, and Outcome of Cytomegalovirus Viremia and Gastroenteritis in Patients with Gastrointestinal Graft-versus-Host Disease.
- Malignant Cause of Abdominal Pain in Leukemia: Spontaneous Splenic Rupture.
- Low-dose antithymocyte globulin enhanced the efficacy of tacrolimus and mycophenolate for GVHD prophylaxis in recipients of unrelated SCT.
- Allotransplantation for patients age 40 years and greater with non-Hodgkin Lymphoma (NHL): encouraging progression-free survival.
- Successful hematopoietic stem Cell collection in patients who fail initial plerixafor mobilization for autologous stem Cell transplant.
- High Incidence of Severe aGVHD with Tacrolimus and Mycophenolate Mofetil in a Large Cohort of Related and Unrelated Allogeneic Transplant Patients.
- Multiple infusions of CD20-targeted T cells and low-dose IL-2 after SCT for high-risk non-Hodgkin's Lymphoma: A pilot study.
- Evaluating the effects of lenalidomide induction therapy on peripheral stem Cells collection in patients undergoing autologous stem Cell transplant for multiple myeloma.
- Long-term follow up of patients proceeding to transplant using plerixafor mobilized stem Cells and incidence of secondary myelodysplastic syndrome/AML.
- A Phase I Dose-Escalation Trial of High-Dose Melphalan with Palifermin for Cytoprotection Followed by Autologous Stem Cell Transplantation for Patients with Multiple M...
- Anti-Thymocyte Globulin (Thymoglobulin), Tacrolimus, and Sirolimus as Acute Graft-versus-Host Disease Prophylaxis for Unrelated Hematopoietic Stem Cell Transplantation.
- Melphalan 180 mg/m(2) can be Safely Administered as Conditioning Regimen prior to an Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma Patients with Crea...
Procedures Preformed
- Bone Marrow Transplant
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anemia
- Breast Cancer
- Chronic Myeloid Leukemia (CML)
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
- Choice Plus POS II
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Cofinity PPO
- Commercial Insurance Company
- Coventry Health Care
- Preferred PPO
- Choice Care PPO
- Medicaid
- Medicare MCR
- Molina
- MultiPlan PPO
- PHCS Network PPO
- Priority PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Education
-
Wayne State University School of Medicine -
Government Medical College Amritsar
Hospital
-
DMC - Detroit Receiving Hospital -
DMC Harper University Hospital
Drug Facts
| NPI NUMBER | 1578746681 | |
| NPPES Provider LastName | DEOL | |
| NPPES Provider FirstName | ABHINAV | |
| NPPES Provider ZIPCode | 482012013 | |
| NPPES Provider State | MI | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 177.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 33.0 | |
| Percent Opioid Claims | 18.64 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1578746681 |
| Last Name Of The Provider | DEOL |
| First Name Of The Provider | ABHINAV |
| View All |
Similar Doctors
|
|
Dr. Paul S. Swerdlow, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Preetha Ramalingam, MD |
|
|
Dr. Joseph A. Fontana, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vainutis K. Vaitkevicius, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Michelle L. Bonnett, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tarek Jazaerly, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel P. Snower, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melissa A. Runge-Morris, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jyotinder N. Punia, MD |
|
|
Dr. Geetika Kukreja, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hemchandra Mahaseth, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sri L. Kollepara, MD |
|
|
Dr. Ananda S. Prasad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bashar Sharaf Aldeen, MD |
|
|
Dr. Dania Khoulani, MD
This Doctor is OpenDoctor Recommended.
|